Francesco Grillone

449 total citations
10 papers, 127 citations indexed

About

Francesco Grillone is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Francesco Grillone has authored 10 papers receiving a total of 127 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Francesco Grillone's work include Renal cell carcinoma treatment (3 papers), Hormonal and reproductive studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). Francesco Grillone is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Hormonal and reproductive studies (2 papers) and Cancer Genomics and Diagnostics (2 papers). Francesco Grillone collaborates with scholars based in Italy, United Kingdom and Spain. Francesco Grillone's co-authors include Pierosandro Tagliaferri, Pierfrancesco Tassone, Michele Caraglia, Nicoletta Staropoli, Alfredo Budillon, Eleonora Iuliano, Salvatore Venuta, Raffaele Costanzo, Liliana Montella and Raffaele Addeo and has published in prestigious journals such as Journal of Clinical Oncology, Frontiers in Immunology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Francesco Grillone

8 papers receiving 127 citations

Peers

Francesco Grillone

ONCOL

PRM

GENET

Farheen Mir United Kingdom

Sara Bastian Switzerland

Barbara Mantoan Italy

Carlos A. Encarnacion United States

Shruti Tiwari United States

Maitri Kalra United States

Ilka Petry Germany

Stefania Pipitone Italy

Dorothy Hallberg United States

Emilie Sohier France

Farheen Mir United Kingdom

Francesco Grillone

74 ×0.9

ONCOL

18 ×0.5

PRM

46 ×1.4

39 ×1.4

25 ×0.9

GENET

Citations per year, relative to Francesco Grillone Francesco Grillone (= 1×) peers Farheen Mir

Countries citing papers authored by Francesco Grillone

Since Specialization

Citations

This map shows the geographic impact of Francesco Grillone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Grillone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Grillone more than expected).

Fields of papers citing papers by Francesco Grillone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Grillone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Grillone. The network helps show where Francesco Grillone may publish in the future.

Co-authorship network of co-authors of Francesco Grillone

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Grillone. A scholar is included among the top collaborators of Francesco Grillone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Grillone. Francesco Grillone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Siciliano, Maria Anna, Maria D’Apolito, Francesco Grillone, et al.. (2025). Do age and performance status matter? A systematic review and network meta-analysis of immunotherapy studies in untreated advanced/metastatic non-oncogene addicted NSCLC. Frontiers in Immunology. 16. 1635056–1635056.

Signori, Alessio, Giuseppe Fornarini, Sarah Scagliarini, et al.. (2025). Evaluating Treatment Efficacy in Metastatic Hormone-sensitive Prostate Cancer Patients with Visceral Disease: A Systematic Review and Network Meta-analysis. European Urology Oncology.

Maruzzo, Marco, Elena Verzoni, Giuseppe Procopio, et al.. (2024). Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney. Clinical Genitourinary Cancer. 22(5). 102186–102186. 1 indexed citations

Basso, Umberto, Sebastiano Buti, Elena Verzoni, et al.. (2023). Cabozantinib in the elderly with metastatic renal cell carcinoma undergoing geriatric G8 screening test: A prospective multicenter observational study (ZEBRA/MEET-URO 9).. Journal of Clinical Oncology. 41(6_suppl). 647–647. 1 indexed citations

Santini, Daniele, Marco Stellato, Ugo De Giorgi, et al.. (2020). Clinical outcomes of metastatic renal carcinoma following disease progression to programmed death (PD)-1 or PD-L1 inhibitors (I-O): A Meet-URO group real-world study (Meet-Uro 7).. Journal of Clinical Oncology. 38(6_suppl). 691–691. 3 indexed citations

Arbitrio, Mariamena, Francesca Scionti, Emanuela Altomare, et al.. (2019). Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case‐Control Study. Clinical Pharmacology & Therapeutics. 106(2). 422–431. 23 indexed citations

Staropoli, Nicoletta, Domenico Ciliberto, Eleonora Iuliano, et al.. (2018). The Era of PARP inhibitors in ovarian cancer: “Class Action” or not? A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 131. 83–89. 35 indexed citations

Bracarda, Sergio, Giuseppe Procopio, Daniele Alesini, et al.. (2014). Enzalutamide activity in patients with metastatic castration resistant prostate cancer (mCRPC) previously responding to antiandrogen withdrawal syndrome (AWS): A preliminary report.. Journal of Clinical Oncology. 32(15_suppl). e16058–e16058. 1 indexed citations

Caraglia, Michele, Raffaele Addeo, Raffaele Costanzo, et al.. (2005). Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours. Cancer Chemotherapy and Pharmacology. 57(1). 34–39. 51 indexed citations

10.

Tagliaferri, Pierosandro, Pierfrancesco Tassone, Simona Blotta, et al.. (2005). Antitumor Therapeutic Strategies Based on the Targeting of Epidermal Growth Factor-Induced Survival Pathways. Current Drug Targets. 6(3). 289–300. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact